Oncolytics Biotech (ONCY) Posts Wider Q4 Loss

Oncolytics Biotech (NASDAQ: ONCY) reported Q4 EPS of ($0.49), $0.39 worse than the analyst estimate of ($0.10).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Royal Unibrew reports higher interim first-half profit as margins improve
• Wendy's U.S. president to resign, company to create COO role